FDA Clears Lyric Hearing Aids for Self-Replacement: Impact on Patients and Professionals

This week, Shari Eberts welcomes Dr. Michelle Wiebke, the Lyric Audiology and Education Manager at Phonak. Dr. Wiebke discusses the recent FDA approval that allows experienced Lyric users in the U.S. to self-replace their devices, a significant development aimed at enhancing accessibility and reducing the need for frequent in-office visits.

This new clearance empowers certified Lyric providers to offer the self-replacement option to their patients, which promises greater convenience and autonomy for users.

Dr. Wiebke elaborates on how this change will impact users' lives, emphasizing the benefits of Lyric's discreet and continuous-wear design. The conversation also covers the fitting process, maintenance, and typical user experience, highlighting the ease of use and minimal upkeep required for Lyric hearing aids. Shari and Dr. Wiebke explore the advancements in hearing aid technology and Phonak's ongoing commitment to improving hearing health through innovation and user-centered solutions.

Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
  / this-week-in-hearing  
  / weekinhearing  

Audio podcast can be found on all major platforms, including Apple & Spotify: https://podcasters.spotify.com/pod/sh...

TIMESTAMPS
00:00 Introduction
01:05 How Lyric is different than traditional hearing aids
03:35 Dr. Wiebke's background with Lyric
05:09 Lyric self-replacement: FDA clearance
07:45 Research behind safety and efficacy of Lyric self replacement
11:42 Self replacement process
13:05 Who is a good candidate for Lyric?
14:48 Tips for providers interested in prescribing Lyric
17:12 Future outlook for Lyric

‪@phonak‬